Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-01 00:49:58 - browse：69

NICOLAS MAETERLINCK/BELGA MAG/AFP via Getty Images

LONDON — Novavax, the beleaguered maker of a Covid-19 vaccine, just got a boost of its own.

The French pharma company Sanofi on Friday said it had reached a licensing deal to sell Novavax’s Covid shot going forward as well as to try to combine the vaccine with Sanofi’s own flu shot. The pact includes a $500 million upfront payment, with up to $700 million more on the table if certain regulatory and launch milestones are reached.

While Novavax’s stock soared during the pandemic as the vaccine race was underway, the company failed to get its shot authorized in the U.S. market until July 2022, long after the makers of mRNA vaccines had reaped billions in sales. Sales have sputtered along since then, and last year, the Maryland-based company warned that that it may not be able to stay in business.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Dana Farber says 6 studies to be retracted and 31 corrected

entertainment

knowledge

WSS

Maisha Meds is a PBM, but don't call it that

TikTok, Instagram influencers need more rules for drug ads

Head of FDA's diagnostics center, who led through Covid, retires

Update the Apgar Score to remove skin color

Johnson & Johnson sues to stop Medicare negotiation

Medicare drug price lawsuits could be good politics for Biden

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

Moonlake's readout produced a cash windfall. Risks remain

Medicare drug price lawsuits could be good politics for Biden

Walensky prepares to leave CDC — and Congress — behind

A strong 6.5

New air purifier tech could be key to improving indoor air quality

Cardiologists urge adding sexual orientation, gender identity to health records

Psychedelics group wrestles with new pharma identity

Inaction leaves children at risk from dangerous chemotherapy drug

Activists slam private health insurers over coverage restrictions

A Theranos scientist

Wikipedia

Dana Farber says 6 studies to be retracted and 31 corrected

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Why you get paid to donate plasma but not blood

CVS is on a mission to consolidate health care. Will it work?

House passes resolution saying Israel isn't a 'racist or apartheid state'

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

leisure time

entertainment

knowledge

Wikipedia